Additionally, previous studies have revealed that FGF2 overexpression in CAFs promotes sprout RTK signaling antagonist 1 (SPRY1) expression in CD8+ T cells and attenuates T cell receptor (TCR)-triggered T cell activation in vitro and in vivo, which could contribute to ESCC progression (52). Here, CD8A is linked to esophageal squamous cell carcinoma.